Literature DB >> 31157059

Pharmacist prescribing in critical care: an evaluation of the introduction of pharmacist prescribing in a single large UK teaching hospital.

Verity J Cross1, James T Parker2, Marie-Christine Y L Law Min2, Richard S Bourne2.   

Abstract

OBJECTIVES: To evaluate the introduction of pharmacist independent prescribing activity across three general critical care units within a single large UK teaching hospital. To identify the prescribing demographics including total of all prescriptions, number prescribed by pharmacists, reason for pharmacist prescription, range of medications prescribed, pharmacist prescribing error rate and the extent of pharmacist second 'clinical check'.
METHODS: Retrospective evaluation of e-prescribing across all general critical care units of a single large UK teaching hospital. All prescribing data were downloaded over a 1-month period (May to June 2016) with analysis of pharmacist prescribing activity including rate, indication, therapeutic class and error rate.
RESULTS: In total, 5374 medicines were prescribed in 193 patients during the evaluated period. Prescribing pharmacists were available on the units on 60.4% (58/96) of days, during their working hours and accounted for 576/5374 (10.7%) of medicines prescribed in 65.2% (126/193) of patients. The majority (342/576) of pharmacist prescriptions were for new medicines. Infections, central nervous system, and nutrition/blood were the top three British National Formulary (BNF) therapeutic categories, accounting for 63.4% (349/576) of all pharmacist prescriptions. The critical care pharmacist prescribing error rate was 0.18% (1/550).
CONCLUSIONS: Pharmacist independent prescribers demonstrated a high degree and wide-ranging scope of prescribing activity in general critical care patients. Pharmacists contributed a significant proportion of total prescribing, despite less than full service coverage. Prescribing activity was also safe with a very low error rate recorded.

Entities:  

Keywords:  critical care; error rate; intensive care; non-medical prescribing; pharmacist; prescribing

Year:  2017        PMID: 31157059      PMCID: PMC6457156          DOI: 10.1136/ejhpharm-2017-001267

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  10 in total

1.  Pharmacist independent prescribing in secondary care: opportunities and challenges.

Authors:  Richard S Bourne; Wasim Baqir; Raliat Onatade
Journal:  Int J Clin Pharm       Date:  2016-02

2.  Impact of the introduction of a specialist critical care pharmacist on the level of pharmaceutical care provided to the critical care unit.

Authors:  Anja Richter; Ian Bates; Meera Thacker; Yogini Jani; Bryan O'Farrell; Caroline Edwards; Helen Taylor; Rob Shulman
Journal:  Int J Pharm Pract       Date:  2016-01-18

3.  Proactive clinical pharmacist interventions in critical care: effect of unit speciality and other factors.

Authors:  Richard S Bourne; Chui Lynn Choo; Ben J Dorward
Journal:  Int J Pharm Pract       Date:  2013-06-13

4.  Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK).

Authors:  R Shulman; C A McKenzie; J Landa; R S Bourne; A Jones; M Borthwick; M Tomlin; Y H Jani; D West; I Bates
Journal:  J Crit Care       Date:  2015-04-18       Impact factor: 3.425

5.  Do we need a pharmacist in the ICU?

Authors:  Clarence Chant; Norman F Dewhurst; Jan O Friedrich
Journal:  Intensive Care Med       Date:  2015-05-21       Impact factor: 17.440

6.  A prospective audit of a nurse independent prescribing within critical care.

Authors:  Martin Carberry; Sarah Connelly; Jennifer Murphy
Journal:  Nurs Crit Care       Date:  2012-11-22       Impact factor: 2.325

7.  Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position.

Authors:  Richard S Bourne; Paul Whiting; Lisa S Brown; Mark Borthwick
Journal:  Int J Pharm Pract       Date:  2015-09-30

8.  On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.

Authors:  Joanna E Klopotowska; Rob Kuiper; Hendrikus J van Kan; Anne-Cornelie de Pont; Marcel G Dijkgraaf; Loraine Lie-A-Huen; Margreeth B Vroom; Susanne M Smorenburg
Journal:  Crit Care       Date:  2010-10-04       Impact factor: 9.097

9.  Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) study.

Authors:  Cristín Ryan; Sarah Ross; Peter Davey; Eilidh M Duncan; Jill J Francis; Shona Fielding; Marie Johnston; Jean Ker; Amanda Jane Lee; Mary Joan MacLeod; Simon Maxwell; Gerard A McKay; James S McLay; David J Webb; Christine Bond
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

10.  We need to optimize piperacillin-tazobactam dosing in critically ill patients-but how?

Authors:  Menino Osbert Cotta; Jason A Roberts; Jeffrey Lipman
Journal:  Crit Care       Date:  2016-06-06       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.